Pharma Reviews: Replacing China as API supplier for pharma will be a medium to long term story: Lupin

The Indian pharmaceutical industry is well poised for growth for some time to come. -Ramesh Swaminathan, Lupin. Likewise, Mylan which had a market ...
Read more: Replacing China as API supplier for pharma will be a medium to long term story: Lupin